Join the Exploding Neoantigens Community
The European Neoantigen Summit is dedicated to advancing neoantigen identification, optimising prediction strategies and accelerating the manufacture of neoantigen-based targeted therapies.
Build a commercial roadmap for the manufacture of personalized therapies at scale and navigate the regulatory minefield to understand how to develop and deliver clinical trials for regulatory approval.
Meet the experts in the field in Amsterdam to analyse the approaches being utilised to measure peptide binders of MHC molecules to improve algorithm accuracy, providing the strongest foundation on which to advance your drug development programme.
Ensure that immunogenic neoantigens become the rule rather than the exception, bringing personalised cancer immunotherapies to new heights.
Hear What Past Neoantigen Summit Attendees Have To Say:
“This meeting was the most comprehensive survey of the emerging field of neoantigen based therapeutics. This was a well organized conference with excellent speakers.”
– Charles Nicolette, Argos Therapeutics
“This meeting was a very efficient way to meet the companies and hear the main players in the field discuss the technologies and the clinical endeavors to use neoantigens in various types of immunotherapy.”
– Dolores Schendel, Medigene